MedeskinAI addresses the unmet needs in primary care and dermatology, offering solutions to reduce delayed appointments, under-served patients, and the risk of worsening skin conditions. It also combats racial bias in healthcare access and provides early intervention for patients, possibly saving lives.

Nearly 27% of GP appointments in the UK NHS are wasted. Medeskin AI reduces wasted appointments by accurately identifying cases that can be treated with over-the-counter remedies, allowing GPs to allocate their time more efficiently.

Medeskin AI allows GPs to quickly assign severe cases to specialist GPs or dermatologists, ensuring that patients with urgent needs receive prompt care and meet the two-week-wait targets.

Patients with skin conditions receive timely and accurate diagnoses, which can prevent conditions from becoming chronic or cancerous. Medeskin AI aims to improve equitable patient satisfaction and access to healthcare, especially in remote or under-resourced areas.

Medeskin AI seeks funding for observation studies, clinical trials, and safety certification. It plans to leverage partnerships, diversity of inputs, and a subscription-based model to scale and provide inclusive dermatology solutions.

Medeskin AI allows GPs to remotely monitor treatment via the Patient-GP-Portal, minimizing wasted appointments, reducing patient travel, and maximizing face-to-face appointments for more deserving cases.